Pharmacokinetic interaction between saquinavir and cyclosporine

被引：29

作者：

Brinkman, K ^{[1
]}

Huysmans, F ^{[1
]}

Burger, DM ^{[1
]}

机构：

[1] Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands

来源：

ANNALS OF INTERNAL MEDICINE | 1998年 / 129卷 / 11期

关键词：

D O I：

10.7326/0003-4819-129-11_Part_1-199812010-00022

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：914 / 915

页数：2

共 5 条

[1] The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].

Kim, RB ;

Fromm, MF ;

Wandel, C ;

Leake, B ;

Wood, AJJ ;

Roden, DM ;

Wilkinson, GR .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294

[2] HIV-1 protease inhibitors and the MDR1 multidrug transporter [J].

Lee, CGL ;

Gottesman, MM .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :287-288

[3] Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients [J].

Merry, C ;

Barry, MG ;

Mulcahy, F ;

Ryan, M ;

Heavey, J ;

Tjia, JF ;

Gibbons, SE ;

Breckenridge, AM ;

Back, DJ .

AIDS, 1997, 11 (04) :F29-F33

[4] MODULATION OF MULTIDRUG-RESISTANT MULTIPLE-MYELOMA BY CYCLOSPORINE [J].

SONNEVELD, P ;

DURIE, BGM ;

LOKHORST, HM ;

MARIE, JP ;

SOLBU, G ;

SUCIU, S ;

ZITTOUN, R ;

LOWENBERG, B ;

NOOTER, K .

LANCET, 1992, 340 (8814) :255-259

[5]

Washington C. B., 1997, Clinical Pharmacology and Therapeutics, V61, P193

← 1 →